Works matching IS 13479032 AND DT 2014 AND VI 105 AND IP 8


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    Cancer Science, 2014, v. 105, n. 8, p. i, doi. 10.1111/cas.12261
    Publication type:
    Article
    13
    14

    Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.

    Published in:
    Cancer Science, 2014, v. 105, n. 8, p. 1040, doi. 10.1111/cas.12449
    By:
    • Tanaka, Hidekazu;
    • Hirata, Michinari;
    • Shinonome, Satomi;
    • Wada, Toru;
    • Iguchi, Motofumi;
    • Dohi, Keiji;
    • Inoue, Makiko;
    • Ishioka, Yukichi;
    • Hojo, Kanji;
    • Yamada, Tomomi;
    • Sugimoto, Tatsuya;
    • Masuno, Koichi;
    • Nezasa, Ken‐ichi;
    • Sato, Norihito;
    • Matsuo, Kenji;
    • Yonezawa, Shuji;
    • Frenkel, Eugene P.;
    • Shichijo, Michitaka
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23